Spectral estimation of human blood for use in cancer detection
暂无分享,去创建一个
Taylor T. Johnson | T. W. Johnson | J. W. Pierre | R. Pappu | R. O. Asplund | R. Asplund | R. Pappu | J. W. Pierre
[1] F. G. Herring,et al. Proton magnetic resonance spectroscopy of plasma from patients with dyslipoproteinemia: identification of factors governing methyl and methylene proton line widths. , 1989, Journal of lipid research.
[2] J. M. Carr,et al. Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. , 1986, The New England journal of medicine.
[3] P. Okunieff,et al. Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors. , 1990, The New England journal of medicine.
[4] I. Zuna,et al. Investigations concerning the potential for using 1h nmr relaxometry or high‐resolution spectroscopy of plasma as a screening test for malignant lung disease , 1990, Magnetic resonance in medicine.
[5] F. G. Herring,et al. The proton NMR of blood plasma and the test for cancer , 1990, Magnetic resonance in medicine.
[6] The Proton Nuclear Magnetic Resonance Spectral Analysis of Human Blood Plasma Lipoprotein , 1989 .
[7] Jimmy D Bell,et al. 1H NMR studies of human blood plasma Assignment of resonances for lipoproteins , 1987, FEBS letters.